Introduction: Computerized tomography (CT) is a crucial technique for determining the severity of COVID-19. Ground glass opacities (GGO), crazy-paving patterns, and parenchymal consolidations are the most frequent patterns. Fibrosis, subpleural lines, the reversed "halo sign," pleural effusion, and lymphadenopathy are additional related CT features. The course and severity of the disease are related to CT results in COVID-19 patients. For patients with COVID-19, evaluation of laboratory and chest CT imaging features for prognostic prediction would be benecial for a better knowledge of disease pathogenesis, risk stratication, and the development of early treatment plans that ultimately minimise mortality Materials and Methods: Present study was performed on 100 laboratory conrmed cases of COVID–19 diagnosed on reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR). Cases were divided into two groups based on clinical disease severity scoring based on the criteria provided by Chinese Centre of Disease Control (CDC)5 as Group A (Disease presenting with dyspnoea, respiratory rate ≥ 30/min and SpO2 ≤ 93%) and Group B (Disease presenting with mild symptoms without dyspnoea, respiratory rate < 30/ min and SpO2 > 93 %). Patients Information on demography, clinical data with symptoms, comorbidity and disease severity were collected. CT Chest was sent in every patient at the time of admission. Observations and Results: Right and left lower lobe was affected in majority i.e 47 (47 %) and 52 (52 %) respectively. In group A moderate 25 (25 %) and severe CT 17 (17 %) score was found in majority whereas in group B mild 33 (33 %) CT score was in majority. Result was statistically signicant (P<0.00001). Ground glass opacity was the main CT pattern found in majority 47 (47 %). In group B compared to group A maximum patients got discharged within 10 days. Also ICU admissions were less 1 (1 %). Result was statistically signicant (P=0.008) Conclusion: Temporal changes of chest CT features and severity scores were closely associated with the outcome of COVID-19, which may be valuable for early identication of severe cases and eventually reducing the morbidity of COVID-19
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.